NIO Inc. Reports Unaudited Fourth Quarter and Full Year 2024 Financial Results

Go back to NIO Inc. Reports Unaudited Fourth Quarter and Full Year 2024 Financial Results

Citi Reiterates Buy Rating on NIO (NIO)

March 25, 2025 10:27 AM EDT

Citi analyst Jeff Chung reiterated a Buy rating and $8.10 price target on NIO (NYSE: NIO).

The analyst comments "Cassava Sciences, Inc. (SAVA; Sell) announced topline results from the Phase 3 REFOCUS-ALZ study of simufilam in mild-to-moderate AD. Simufilam is a proprietary, investigational oral... More

NIO (NIO) PT Lowered to $4.90 at BofA Securities

March 21, 2025 2:40 PM EDT

BofA Securities analyst Ming Hsun Lee lowered the price target on NIO (NYSE: NIO) to $4.90 (from $5.00) while maintaining a Neutral rating.

The analyst comments "Management guided 41-43k units of vehicle delivery (+36% to +43% YoY) and RMB12.4- 12.9bn (+25% to +30% YoY). Accordingly, we raise our... More

Morgan Stanley Reiterates Overweight Rating on NIO (NIO)

March 21, 2025 6:39 AM EDT

Morgan Stanley analyst Tim Hsiao reiterated an Overweight rating and $5.90 price target on NIO (NYSE: NIO)

The analyst comments "NIO reported a net loss of Rmb7.1bn in 4Q24 (vs. Rmb5.1bn loss in 3Q24), higher than our expectation of a Rmb5.8bn loss. Full-year losses arrived at Rmb22.4bn vs. 20.7bn in... More